Using Stem Cells to Treat Corneal Blindness
Author Information
Author(s): Setiawan Abdul Malik, Kamarudin Taty Anna, Tsamesidis Ioannis
Primary Institution: Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia
Hypothesis
Can human mesenchymal stem cells (MSCs) be effectively differentiated into corneal epithelial cells to treat corneal blindness?
Conclusion
The review highlights the potential of MSCs, particularly adipose-derived stem cells, in differentiating into corneal epithelial cells, offering a promising alternative for treating corneal blindness.
Supporting Evidence
- Corneal blindness affects millions and is often treated with corneal transplants, which are limited by donor availability.
- MSCs can be derived from various tissues and have shown potential in regenerative medicine.
- Chemical induction methods using BMP4 and ATRA have been effective in differentiating MSCs into corneal epithelial cells.
Takeaway
Scientists are exploring how to turn special cells from fat into eye cells that can help people see better when they have eye problems.
Methodology
The review analyzes various methods for differentiating MSCs into corneal epithelial cells, including chemical induction and co-culture techniques.
Potential Biases
Potential biases may arise from the selective reporting of studies that show positive outcomes for MSC differentiation.
Limitations
The review does not provide new experimental data and relies on existing literature, which may have varying methodologies and outcomes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website